BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 31437480)

  • 1. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
    Bahji A; Forsyth A; Groll D; Hawken ER
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
    Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
    Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ
    J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
    Ot'alora G M; Grigsby J; Poulter B; Van Derveer JW; Giron SG; Jerome L; Feduccia AA; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
    Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
    Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple session early psychological interventions for the prevention of post-traumatic stress disorder.
    Roberts NP; Kitchiner NJ; Kenardy J; Robertson L; Lewis C; Bisson JI
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD006869. PubMed ID: 31425615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
    Feduccia AA; Jerome L; Mithoefer MC; Holland J
    Psychopharmacology (Berl); 2021 Feb; 238(2):581-588. PubMed ID: 33221932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents (Review).
    Gillies D; Taylor F; Gray C; O'Brien L; D'Abrew N
    Evid Based Child Health; 2013 May; 8(3):1004-116. PubMed ID: 23877914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.
    Gorman I; Belser AB; Jerome L; Hennigan C; Shechet B; Hamilton S; Yazar-Klosinski B; Emerson A; Feduccia AA
    J Trauma Stress; 2020 Apr; 33(2):161-170. PubMed ID: 32073177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents.
    Gillies D; Taylor F; Gray C; O'Brien L; D'Abrew N
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006726. PubMed ID: 23235632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Psychiatric Uses for MDMA.
    Yazar-Klosinski BB; Mithoefer MC
    Clin Pharmacol Ther; 2017 Feb; 101(2):194-196. PubMed ID: 27859039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for posttraumatic stress disorder.
    Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
    Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological treatment of post-traumatic stress disorder (PTSD).
    Bisson J; Andrew M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD003388. PubMed ID: 17636720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment.
    Vermetten E; Yehuda R
    Neuropsychopharmacology; 2020 Jan; 45(1):231-232. PubMed ID: 31455855
    [No Abstract]   [Full Text] [Related]  

  • 18. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD.
    Brewerton TD; Lafrance A; Mithoefer MC
    Med Hypotheses; 2021 Jan; 146():110367. PubMed ID: 33203569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
    Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R
    PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
    Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
    J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.